Investigation Overview
June 25, 2013 (Update) - On June 11, 2013, an article was published asserting that Celsion Corporations statistical findings from the Phase III study should be viewed with extreme skepticism and that having reviewed the Phase III results and subgroup analysis, all the doctors we spoke with unanimously believed that Celsion Corporation has no chance of regulatory approval. Shares of ...
You must register (for free) or login to view the entire investigation.